Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
269.86 AUD | -1.10% |
|
-3.77% | -4.16% |
Dec. 13 | CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema | CI |
Oct. 30 | CSL Limited Engages in Discussions with Cara Therapeutics | CI |
- Stock Market
- Equities
- CSL Stock
- Charts CSL Limited
- News Chart